Skip to the page

Data / Drug companies / Archimica S.p.A.

Archimica S.p.A.: 22 products in the FDA NDC directory, labeler code 55512

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Archimica S.p.A. (labeler code 55512) lists 22 products in the FDA National Drug Code Directory. By type: 22 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 17, 2019.

The request: Watch Archimica S.p.A. (FDA labeler code 55512): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
55512
Products in commercial distribution
22
Packages
22
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
July 30, 2009
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients22100%

Products by type

TypeProductsShare
Bulk ingredients22100%

Dosage forms

Dosage formProductsShare
Powder22100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Cytarabine55512-0026PowderBulk ingredientsDecember 17, 2019
Pirenzepina base pura55512-0025PowderBulk ingredientsAugust 2, 2018
Oxcarbazepine55512-0023PowderBulk ingredientsFebruary 12, 2018
Pentetrazole55512-0024PowderBulk ingredientsMay 10, 2016
Glycerylphosphorylcholine anhydrous55512-0022PowderBulk ingredientsJanuary 28, 2014
Sucralfate55512-0021PowderBulk ingredientsJanuary 28, 2014
Sucralfate55512-0020PowderBulk ingredientsJanuary 28, 2014
Sucralfate55512-0019PowderBulk ingredientsSeptember 18, 2012
Oxcarbazepine55512-0018PowderBulk ingredientsJune 26, 2012
Oxcarbazepine55512-0017PowderBulk ingredientsJune 26, 2012
Oxcarbazepine55512-0016PowderBulk ingredientsJune 26, 2012
Capecitabine55512-0015PowderBulk ingredientsApril 20, 2011
Hydralazine hydrochloride55512-0010PowderBulk ingredientsNovember 30, 2009
Bromfenac sodium salt sesq hydrate55512-0013PowderBulk ingredientsNovember 18, 2009
Sucralfate55512-0009PowderBulk ingredientsSeptember 9, 2009
Oxcarbazepine55512-0008PowderBulk ingredientsSeptember 9, 2009
Oxcarbazepine55512-0007PowderBulk ingredientsSeptember 9, 2009
Oxcarbazepine55512-0006PowderBulk ingredientsSeptember 9, 2009
Disopyramide phosphate55512-0004PowderBulk ingredientsSeptember 9, 2009
Hydroxyurea55512-0003PowderBulk ingredientsSeptember 9, 2009
Sulfapyridine55512-0001PowderBulk ingredientsSeptember 9, 2009
Sucralfate55512-0002PowderBulk ingredientsJuly 30, 2009

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.